首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 42 毫秒
1.
PURPOSE: To present the results of dextrose prolotherapy undertaken for chronic non-responding coccygodynia in 37 patients. METHODS: 14 men and 23 women (mean age, 36 years) with chronic coccygodynia not responding to conservative treatment for more than 6 months were included. 27 of them had received local steroid injections. A visual analogue score (VAS) was recorded for all patients before and after injection of 8 ml of 25% dextrose and 2 ml of 2% lignocaine into the coccyx. In 8 patients with a VAS of more than 4 after the second injection, a third injection was given 4 weeks later. RESULTS: The mean VAS before prolotherapy was 8.5. It was 3.4 after the first injection and 2.5 after the second injection. Minimal or no improvement was noted in 7 patients; the remaining 30 patients had good pain relief. CONCLUSION: Dextrose prolotherapy is an effective treatment option in patients with chronic, recalcitrant coccygodynia and should be used before undergoing coccygectomy. Randomised studies are needed to compare prolotherapy with local steroid injections or coccygectomies.  相似文献   

2.
《Foot and Ankle Surgery》2021,27(6):643-649
In the recent years, prolotherapy is increasingly being used in the field of musculoskeletal medicine. However, few studies have investigated its effectiveness in plantar fasciitis (PF). The purpose of this study was to compare the effectiveness of ultrasound-guided dextrose prolotherapy with radial extracorporeal shock wave therapy (ESWT) in the treatment of chronic PF. This randomized controlled trial was conducted on 59 patients with chronic PF. Patients were randomly assigned into two groups receiving three sessions of radial ESWT (29 patients) vs. two sessions of ultrasound-guided intrafascial 2 cc dextrose 20% injection (30 patients). The following outcome measures were assessed before and then six weeks and 12 weeks after the treatments: pain intensity by visual analog scale (VAS), daily life and exercise activities by Foot and Ankle Ability Measure (FAAM), and the plantar fascia thickness by ultrasonographic imaging. The VAS and FAAM scales showed significant improvements of pain and function in both study groups 6 weeks and 12 weeks after the treatments. A significant reduction was noted for plantar fascia thickness at these intervals (all p < .05). The inter-group comparison revealed that except for the FAAM-sport subscale which favored ESWT, the interaction effects of group and time were not significant for other outcome measures. Dextrose prolotherapy has comparable efficacy to radial ESWT in reducing pain, daily-life functional limitation, and plantar fascia thickness in patients with PF. No serious adverse effects were observed in either group.Level of evidenceLevel I, randomized controlled trial.  相似文献   

3.
目的:评估腰椎间盘突出症手术治疗的长期疗效,探讨影响手术长期疗效的相关因素。方法:回顾性分析1996年2月~2002年12月在我院采用单纯开窗减压髓核摘除术治疗的125例单节段腰椎间盘突出症患者,记录患者性别、年龄、体重指数(body mass index,BMI)、病程、临床表现、体征、手术减压时椎间盘的突出类型和末次随访时复发性椎间盘突出症的例数。分别记录术前和末次随访时Oswestry伤残指数(Oswestry Disability Index,ODI)及腰痛/下肢根性痛的视觉模拟评分(visual analog scale,VAS)。根据Stauffer-Coventry′s(SC)疗效评定标准评价患者总体疗效。单因素分析患者术前与末次随访时的VAS以及ODI。患者总体疗效作为结果变量,单因素分析年龄、性别、BMI、吸烟、腰扭伤史、病程、术前腰痛VAS评分、术前下肢痛VAS评分、术前ODI、直腿抬高试验(straight-leg raise test,SLR)、肌力、感觉、椎间盘突出节段和类型等14项指标与疗效的关系。用非条件Logistic全回归分析和逐步回归分析来研究结果变量与术前各种指标的关系。结果:随访84~123个月,平均109个月,患者总体疗效优占32%,良占35.2%,可占23.2%,差占9.6%,复发率为8%。术前ODI为(72.23±25.72)%,末次随访时为(15.64±17.52)%,与术前比较有显著性差异(P<0.05)。腰痛VAS评分术前为5.44±3.43分,末次随访时为2.12±2.32分;下肢痛VAS评分术前为7.34±3.72分,末次随访时为1.42±2.74分;末次随访时与术前比较均有显著性差异(P<0.05)。全回归分析发现腰扭伤史、感觉减退是总体疗效不佳的相关因素,而非包含型突出类型是总体疗效佳的相关因素。逐步回归分析发现有4个有统计学意义的相关因素,其比值比(OR)及95%可信区间分别为:腰扭伤史(OR=6.50;95%CI 2.21-19.10)、吸烟(OR=4.48;95%CI 1.51-13.34)、感觉(OR=9.01;95%CI 1.75-46.46)、突出类型(OR=0.027;95%CI 0.005-0.145)。结论:手术治疗可以明显改善腰椎间盘突出症患者的腰痛、下肢痛和ODI。腰扭伤史、吸烟史、术前感觉和突出类型是影响腰椎间盘突出症手术长期疗效的相关因素。  相似文献   

4.
This study aimed to compare the effectiveness of extracorporeal shockwave therapy (ESWT) versus dextrose prolotherapy on pain and foot functions in patients with chronic plantar fasciitis with a prospective randomized-controlled trial. A total of 29 patients in whom conservative care failed were enrolled for the study after the clinical and ultrasonographic assessment. The patients were randomly assigned to receive ESWT (ESWT group, n = 15) or dextrose prolotherapy (dextrose prolotherapy group, n = 14). ESWT group received 1800 to 2000 focused shock waves (session of 0.20-0.30 mJ/mm2 with a frequency of 4-6 Hz) followed by soft tissue 3000 to 3500 radial pulses (session of 1.8-3.0 bar with a frequency of 15-21 Hz). Dextrose prolotherapy group underwent an injection of 5 ml 15% dextrose solution with 2% lidocaine. ESWT and dextrose prolotherapy were repeated 3 times by 2 weeks apart. A 100-mm Visual Analog Scale (VAS) for overall and morning pain, Foot Function Index (FFI) and the Roles and Maudsley Scale score (RMS) were assessed at baseline, 6 weeks, and 12 weeks after the last intervention. Overall VAS, Morning VAS, RMS and FFI scores improved significantly in both treatment groups at 6 weeks and 12 weeks compared to baseline (p < .001). Comparison of changes in overall VAS, Morning VAS, RMS and FFI scores did not show a significant difference between the groups at each time point (p > .05) In our study dextrose prolotherapy and ESWT had similar effectiveness in patients with chronic plantar fasciitis who have not respond to conservative care. The results showed ESWT and dextrose prolotherapy were not superior to each other  相似文献   

5.
Nirschl手术治疗顽固性网球肘:切开与关节镜手术比较   总被引:2,自引:0,他引:2  
目的 比较切开和关节镜手术治疗顽固性网球肘的临床疗效.方法 2006年5月至2008年9月连续收治顽固性网球肘患者26例(28例肘),手术时患者平均年龄45岁(32~62岁),保守治疗时间为23个月(4~60个月).手术方式以Nirschl术为原则,按照随机表随机分为切开组(13例13肘)和关节镜组(13例15肘).采用VAS疼痛评分、Mayo功能评分、肘关节综合评分、重返工作和运动时间、满意度等评价患者术后效果.结果 26例患者均获随访,随访时间4~32个月,平均17.4个月.两组术后效果比较,在VAS疼痛评分中的静息和日常活动评分、综合评分、重返工作和运动时间、满意度及术后效果评价等级方面,两组均无显著差异.而在VAS评分的运动评分及Mayo功能评分中,切开组优于关节镜组.切开组满意或部分满意患者100%,关节镜组86.7%.切开组优良率100%,关节镜组93.3%.术后未发现严重并发症.结论 切开和关节镜手术均是治疗顽固性网球的有效方法,切开手术在术后恢复运动等肘关节功能方面优于关节镜手术,可能与切开术中有更多伸肌腱裂口被缝合有关.  相似文献   

6.
目的探讨后路脊柱显微内镜下腰椎椎间盘髓核摘除术(microendoscopydiscectomy,MED)中类固醇激素神经根鞘内注射的临床应用效果。方法2006年3月~201t年3月收治的360例腰椎椎间盘突出患者随机分为2组,MED神经根鞘内注射组治疗180例,后路脊柱显微内镜下摘除突出的髓核组织并在神经根鞘内注入5mg地塞米松;MED组180例,手术方法相同,但不注射地塞米松。记录2组手术前后疼痛视觉模拟量表(visualanaloguescale,VAS)评分、直腿抬高角度及恢复正常工作的时间。结果MED神经根鞘内注射组术前VAS评分为6.8±0.8,术后VAS评分为2.1±0.4;MED组术前VAS评分为6.7±0.6,术后VAS评分为3.6±0.7,术后2组疼痛均有明显的改善,MED神经根鞘内注射组改善更明显(P〈0.01)。MED神经根鞘内注射组直腿抬高术前为28.4°±13.0°,术后为67.0°±12.0°;MED组术前为27.6°±11.0°,术后为51.0°±17.0°,2组术后直腿抬高都有明显改善,MED神经根鞘内注射组改善更明显(P〈0.01)。MED神经根鞘内注射组恢复正常生活时间为12d,MED组为21d,MED神经根鞘内沣射组比MED组恢复时间最苫缩短。结果后路脊柱显微内镜能对神经根进行高倍放大,从而进行精确鞘内注射,鞘内注射类闺醇激素治疗腰椎椎间盘突出能显著改善术后疼痛、恢复肢体活动范围及更早的恢复日常生活。  相似文献   

7.
[目的]评价腰椎间盘突出症患者手术治疗与非手术治疗的远期疗效.[方法]对2000年1月~2002年12月在本院住院治疗的377例腰椎间盘突出症患者进行随访,分析患者手术和非手术治疗前后VAS、ODI的改善情况,同时比较手术和非手术治疗后SF - 36生活量表的变化.[结果]共获得有效随访99人,随访率为26.3%.下腰痛VAS评分,手术组(52例)术前:5.84,末次随访:1.78.非手术组(47例)治疗前:6.03,末次随访:2.17,两组治疗前后下腰痛VAS评分有显著差异,但两组疗效间没有显著差异.下肢放射痛VAS评分,手术组(52例)术前:7.45,末次随访:1.52;非手术组(47例)治疗前:5.72,末次随访:2.21,两组治疗前后下肢痛VAS评分有显著差异,两组疗效间有显著差异.Oswestry伤残指数(ODI),手术组(52例)术前:68.18%,末次随访:13.44%;非手术组(47例)治疗前:60.98%,末次随访:17.04%,两组治疗前后ODI有显著差异,两组间没有显著差异.SF - 36生存质量调查问卷评分结果显示,治疗后手术组与非手术组相比患者在躯体健康(PF)、躯体角色功能(RP)、躯体疼痛(BP)、生命活力(VT)、情绪角色功能(RE)等5个维度上没有显著性差异(P>0.05);总体健康(GH)、心理健康(MH)和社会功能(SF)手术组较非手术组有显著性差异(P<0.05).[结论]本组随访资料显示腰椎间盘突出症手术组和非手术治疗组均有较好的远期疗效.手术治疗能更好地缓解腰椎间盘突出症患者的下肢放射痛,对恢复患者的总体健康、心理健康和社会功能也有积极作用.  相似文献   

8.
目的观察评估经皮脊柱内镜腰神经根减压术(PELD)术后腰腿疼痛症状的早期改善进展。 方法对解放军总医院2015年1月至2016年1月连续93例中84例PELD治疗腰背痛及神经根性疼痛症状的患者,前瞻性记录术后12周(各1周1次)的腰背痛视觉模拟评分(VAS)和下肢痛VAS,观察评估两种疼痛症状的改善进展并比较两者的改善度,用术后12周时腰背痛及下肢痛VAS、功能障碍指数评分(ODI)和改良MacNab疗效评定标准评价手术疗效。 结果腰背痛症状术后VAS评分相邻两周间比较,差异无统计学意义(P> 0.05);下肢痛症状术后VAS评分的术后2周与术后1周比较[(2.96 ± 1.97)分 vs (2.10 ± 1.29)分]、术后4周与术后3周比较[(2.04 ± 1.62)分 vs (2.46 ± 1.97)分],差异有统计学意义(P<0.05);余下相邻两周间比较,差异无统计学意义(P > 0.05);下肢痛术后12周VAS改善度与腰背痛VAS改善度比较[(6.64 ± 1.47)分 vs (3.36 ± 1.38)分],差异有统计学意义(P < 0.05);术后12周时ODI、腰背痛VAS、下肢痛VAS均较术前显著降低[(12.82 ± 6.39)分 vs (53.64 ± 11.73)分、(1.16 ± 1.06)分 vs (4.52 ± 0.65)分、(1.29 ± 1.30)分 vs (7.93 ± 0.81)分],改良MacNab疗效评定标准评价优良率为86%。 结论PELD术后早期12周,腰背痛的症状改善平稳,下肢痛的症状改善在术后2周、术后3周出现波动,下肢痛症状比腰背痛症状改善更快,手术疗效显著。  相似文献   

9.
《Foot and Ankle Surgery》2022,28(7):879-882
BackgroundHeel pain is a common condition and often involves the Achilles tendon and is classified as insertional or non-insertional. Several operative and non-operative treatments have been described, but there is no consensus on the most effective therapy. The aim of this study is to evaluate a case series of patients with insertional Achilles tendinopathy refractory to conservative treatment submitted to a single-dose ultrasound-guided injection of hyaluronic acid (40 mg/2.0 mL).MethodsWe prospectively included 25 patients (29 feet) who underwent a single ultrasound-guided injection of hyaluronic acid after conservative treatment failure. Clinical outcomes such as pain (using the Visual Analog Scale – VAS), function (using the American Orthopedic Foot & Ankle Society – AOFAS score), personal satisfaction, and complications were evaluated. Statistical analysis was performed using the R software.ResultsMost patients were female (80%) and there was a right-side predominance (55%). The median VAS was 8 points [range 4–10] at baseline, decreasing to 3 points [range 0–8] at the six-month follow-up, with statistical significance (p < .001). The median AOFAS score was 71 points [range 38–87] at baseline, increasing to 90 points [range 48–100] at the six-month follow-up (p < .001). The personal satisfaction level was 69%, and 48% of patients considered the result excellent. There were no Achilles tendon ruptures, infections, or allergic reactions post injection.ConclusionSingle-dose injection of hyaluronic acid is a safe treatment option, improving function and reducing pain for six months in patients with insertional Achilles tendinopathy after conservative treatment failure.Level of evidenceIV, case series.  相似文献   

10.
The present study evaluated the effectiveness of ultrasound-guided aspiration/injection of ganglion cysts in the lower extremities (knee and foot) that required referral to the radiology department for precise localization. The present study is the first series to describe such results. The study population consisted of 15 patients who had undergone treatment from April 2012 to January 2015. Follow-up was by telephone survey, which was performed at a mean of 15 ± 6 months after treatment. Almost 90% of patients experienced immediate improvement in symptoms (mostly pain), and 77% of these patients had not experienced a recurrence of symptoms at a mean follow-up time of 14 ± 6 months. In conclusion, ultrasound-guided therapy is a safe and potentially effective treatment for most cases of symptomatic lower extremity ganglion cysts.  相似文献   

11.
目的探讨超声引导下注药治疗腹股沟疝术后疼痛并发症应用价值的初步评估。 方法回顾性分析2018年6月至2019年8月,解放军总医院第一医学中心超声诊断科治疗15例因腹股沟疝术后不明原因且无法缓解疼痛的患者,行超声引导下对髂腹下神经、髂腹股沟神经及生殖股神经生殖支周围软组织区域进行注药治疗,应用疼痛视觉模拟评分(VAS)来分别评估术前、术后24 h、48 h、2周、4周的疼痛缓解情况。 结果在超声引导下进行髂腹下神经、髂腹股沟神经及生殖股神经生殖支周围软组织区域注药治疗后,患者短期疼痛明显缓解,24 h尤为显著,术前、术后24 h、48 h、2周、4周的VAS评分比较分别为(3.5±0.8)、(0.7±0.8)、(1.5±1.0)、(2.5±0.8)、(2.7±0.8)分,治疗前与治疗后各时间点比较,差异均有统计学意义(P<0.05),但治疗术后2周与4周的VAS评分比较,差异无统计学意义(P>0.05)。 结论超声引导下注药治疗腹股沟疝术后疼痛,短期临床效果显著,且具有实时引导、安全、无辐射等优点,故可作为临床缓解腹股沟疝术后疼痛的一种有效的治疗方法。  相似文献   

12.
人工髓核置换术治疗腰椎间盘病变的中远期随访结果   总被引:1,自引:0,他引:1  
Ma YZ  Xue HB  Chen X  Guo LX  Li HW  Liu HR 《中华外科杂志》2008,46(5):350-353
目的 探讨人工髓核置换术治疗腰椎间盘病变的中远期疗效和影响因素.方法 回顾性分析2002年3月至2003年10月采用人工髓核置换术治疗的34例腰椎间盘病变患者的临床资料.其中椎间盘源性腰痛20例,腰椎间盘突出症14例;随访时间48~66个月,平均52.6个月.采用Oswestry功能障碍指数(ODI)评分和疼痛视觉模拟评分法(VAS)评估患者术后改善情况和中远期功能.术前ODI评分平均58.4%,VAS评分平均7.4分.对放射学资料进行手术节段活动度、手术节段椎间隙高度变化对比研究.结果 术后早期腰痛及下肢痛症状明显缓解,术后12个月ODI评分平均18.2%,VAS评分平均1.8分,椎间隙高度较术前平均增加17.6%,手术节段活动度平均为9.2°.末次随访时,患者下肢放射性疼痛缓解满意,18例患者下腰痛逐渐加重,ODI评分平均为31.2%,VAS评分平均为3.1分.椎间隙高度较术前平均下降13.5%,手术节段活动度平均为6.8°,植入物移位发生率73.5%(25/34),软骨终板退变损伤发生率64.7%(22/34).结论 人工髓核置换术尚不能达到长期维持手术节段椎间隙高度的目的 ,术后手术节段活动度逐渐减少,下腰痛逐渐加重影响其中远期疗效,明确术前诊断和严格手术指征非常重要.  相似文献   

13.
BackgroundDouble disruptions of the superior suspensory shoulder complex, commonly referred to as ‘floating shoulder’ injuries, are ipsilateral midshaft clavicular and scapular neck/body fractures with a loss of bony attachment of the glenoid. The treatment of ‘floating shoulder’ injuries has been debated controversially for many years. The purpose of this study was to demonstrate the clinical and functional outcomes of patients with ‘floating shoulder’ injuries who underwent operative fixation of the clavicle fracture only.ResultsAll injuries were the result of high-energy mechanisms. Fracture union of the clavicle was seen after initial surgical fixation in the majority of patients (12; 92.3 %). Final pain was reported as minimal (11 cases; 1–3 VAS), moderate (1 case; 4–6 VAS), and high (1 case; 7–10 VAS) at last follow-up. Excellent range of motion (180° forward flexion and abduction) was observed in the majority of patients (8; 61.5 %). The Herscovici score was 12.9 (range 10–15) at 3 months. Unplanned surgeries included two clavicular implant removals and one nonunion revision. None of the patients required reconstruction for scapula malunion after nonoperative management. Twelve patients returned to previous work without restrictions.Conclusions‘Floating shoulder’ injuries with only clavicular fixation return to function despite persistent scapular deformity and some residual pain.Level of evidence Level IV.  相似文献   

14.
Introduction

A unilateral vertical sacral fracture that exits medial or through the L5-S1 facet joint is considered to affect the lumbo-sacral integrity, and it is denoted as an indication for surgical fixation. However, no studies have analysed the outcomes after non-operative treatment of such injuries.

Methods

A retrospective review of all sacral fractures treated over a five-year period was performed to identify patients with Isler’s fractures. Demographic and surgical data, all pre-operative and follow-up images (AP radiographs, CT images), functional outcomes based on VAS, SF-12 and return to work were documented for all patients.

Results

The incidence of Isler’s fractures was 18% (34/181). The mean age was 42.12 ± 16.3 years. As per Isler’s subtypes, fractures passed through L5-S1 joint in 13 (Type 2a) and medial to it in 15 (Type 2b), fractures of L5 or S1 facets in 3 (Type 1), Type 3 injuries were not detected. All patients had concomitant pelvic ring injuries. Sixteen fractures (neurologically intact, < 1 cm displacement, anterior ring stable, no facetal dislocation) were treated non-operatively while 18 patients underwent surgery. At a mean of 15.2 months, the fractures had united in all patients radiographically. The mean VAS score for low back pain (1.4 ± 1.01 vs 1.5 ± 0.79), ability to squat and sit cross-legged (56.3% vs 55.6%) and return to work (68.8% vs 66.7%), and Majeed score (77.2 ± 3.9 vs 79.6 ± 4.1) were similar in non-surgical and surgical groups, respectively, at the final follow-up.

Conclusion

Our study indicates that 47% of Isler’s fractures were mechanically stable and could be effectively treated non-operatively with good radiological and functional outcomes.

  相似文献   

15.
目的探讨腰椎间盘内镜技术(microendoscopic disectomy,MED)结合类固醇激素神经根鞘内注射治疗腰椎间盘突出症的效果。方法 2010-02—2012-12收治的60例腰椎椎间盘突出患者随机分为MED组30例,行MED手术,MED神经根鞘内注射组治疗30例,行MED手术并在神经根鞘杰注入5 mg地塞米松。记录两组手术前后疼痛视觉模拟量表(visualanalogue scale,VAS)评分、直腿抬高角度及术后恢复正常工作的时间,术中、术后并发症发生情况。结果与治疗前比较,两组患者治疗后VAS评分明显减低,直腿抬高角度明显升高,差异有统计学意义(P0.05);与MED组比较,MED神经根鞘内注射组患者治疗后VAS评分及直腿抬高角度的改变更明显,差异有统计学意义(P0.05);MED神经根鞘内注射组患者治疗后恢复正常工作时间明显短于MED组患者(P0.05);MED神经根鞘内注射组患者出现2例并发症,发生率6.7%,术中硬脊膜撕裂并出现脑脊液漏1例,术后因侧隐窝减压不充分和瘢痕粘连再手术1例;MED组患者出现切口感染1例,发生率为3.3%(P0.05)。结论后路脊柱显微内镜结合鞘内注射类固醇激素治疗腰椎椎间盘突出,能显著改善术后疼痛、恢复肢体活动范围及更早的恢复日常生活。  相似文献   

16.
目的 观察超声引导下骶裂孔注射联合针刺治疗腰椎管狭窄症(LSS)的效果。方法 将60例LSS患者随机分为观察组和对照组,每组30例。给予对照组常规针刺治疗,观察组针刺治疗+超声引导下骶裂孔注射复方倍他米松注射液+利多卡因+0.9%氯化钠混合液。对比治疗前及治疗4周结束时(治疗后)2组视觉模拟量表(VAS)评分、功能障碍问卷(RDQ)、直腿抬高(SLR)、腰部活动范围(ROM)、站立行走计时(TUG)及6分钟步行(SMW)距离。结果 观察组28例一次性完成注射,2例因骶裂孔定位失误致首次注射失败,再次定位后注射成功;注射后即刻1例出现尿失禁,注射后48 h内6例短暂性疼痛加重、3例面部潮红,均自行缓解;术中及术后均未见神经损伤、感染或血肿等并发症。治疗后观察组腰部和下肢VAS评分、RDQ和TUG均较治疗前降低(P均<0.01),且均低于对照组(P均<0.05);SLR、腰部屈曲和伸展ROM及SMW距离均较治疗前增加(P均<0.05),且SLR及SMW距离均高于对照组(P均<0.05)。治疗后随访3个月期间,观察组复发率16.67%(5/30),低于对照组的43.3...  相似文献   

17.
《The spine journal》2022,22(5):747-755
BACKGROUND CONTEXTLumbar canal stenosis due to degenerative lumbar spondylolisthesis is one of the most common indications for lumbar spinal surgery. However, from a long-term perspective, it is still unclear which of these procedures should be performed: decompression, decompression plus fusion, or decompression plus stabilization.PURPOSEThis study aimed to present the long-term results of a randomized controlled trial of surgery for degenerative spondylolisthesis.STUDY DESIGN/SETTINGThis is a long-term follow-up of a previously reported randomized controlled trial.PATIENT SAMPLEPatients aged ≤75 years with single L4/5 level lumbar canal stenosis caused by degenerative lumbar spondylolisthesis were enrolled at two hospitals from May 1, 2003, to April 30, 2012; the final follow-up was on May 20, 2021.OUTCOME MEASURESThe following data were collected: modified Japanese Orthopedic Association (JOA) score, visual analog scale (VAS) score for lower back pain, leg pain, and numbness, and scores from eight Short-Form 36 (SF-36) subscales preoperatively, 1 year postoperatively, 5 years postoperatively, and at the final follow-up.METHODSPatients were randomized to undergo decompression alone, decompression plus fusion, or decompression plus stabilization. The primary outcome measure was the change in VAS for lower back pain with secondary outcomes including the modified JOA score, VAS for leg pain, VAS for leg numbness, eight SF-36 subscale scores, and occurrence of reoperation at the last follow-up.RESULTSAmong 85 patients who were randomized, 66 responded to the current survey. The mean follow-up period was 12.3 years. The VAS score for low back pain improvement was not significantly different between the decompression and fusion groups at the mean follow-up of 12.3 years. Of the 12 secondary outcomes, 8 showed no significant difference between decompression and fusion, 12 showed no significant difference between decompression and stabilization, and 10 showed no significant difference between fusion and stabilization.CONCLUSIONSAlthough additional instrumentation surgery did not significantly improve low back pain at the mean follow-up of 12.3 years compared with decompression alone, fusion surgery provided clinically meaningful improvements in patient-reported vitality, social functioning, role limitations due to personal or emotional problems, and mental health compared with decompression alone.TRIAL REGISTRATIONUMIN000028114  相似文献   

18.
《Arthroscopy》2020,36(12):2965-2972
PurposeTo evaluate the prognostic value of an ultrasound-guided subscapular local anesthetic and cortisone injection in a consecutive series of patients who underwent an arthroscopic superior medial scapuloplasty for snapping scapula syndrome (SSS) and had been refractory to conservative treatment.MethodsWe undertook an arthroscopic superior medial scapuloplasty on patients with a clinical diagnosis of SSS who had failed a structured physiotherapy program and had either gained a good response or no to minimal response to preoperative ultrasound-guided subscapular local anesthetic and cortisone injection. The patients were assessed preoperatively and at final follow-up with the QuickDASH and Constant scores, and their pain was assessed with a visual analog scale (VAS).ResultsBetween January 2009 and December 2016, 47 patients were included in the study, with a minimal follow-up of 2 years. There were 29 female and 18 male patients, and the mean age at the time of surgery was 27.4 years (range 15 to 61). Forty-two patients were available at final follow-up. There were 31 patients in the good response group and 11 patients in the no to minimal response group. For all patients, the mean time to follow-up was 41.8 months (range 24 to 108). There was a significant improvement after surgery in the mean QuickDASH score (from 39 to 20, P < .001) (minimal clinically important difference [MCID] 15.91) , Constant score (from 57 to 87, P < .001) (MCID 10.4), and VAS (from 6 to 2, P < .001) (MCID 3). For the good response group, there was a significant improvement after surgery in the mean QuickDASH score (from 38 to 18, P < .001) (MCID 15.91), the Constant score (from 57 to 89) (MCID 10.4), and the VAS (from 6 to 2, P < .001) (MCID 3). For the no to minimal response group, there was a significant improvement after surgery in the mean QuickDASH score (from 42 to 24, P < .01) (MCID 15.91), the Constant score (from 58 to 80, P < .002) (MCID 10.4), and the VAS (from 6 to 2, P < .01) (MCID 3). The difference in postoperative improvement of the QuickDASH and Constant scores between the good response and the no to minimal response groups was statistically significant (P < .05).ConclusionThe results of this study suggest that arthroscopic scapuloplasty can lead to a significant improvement in pain and function in all patients with a clinical diagnosis of snapping scapula syndrome refractory to conservative treatment. Patients who gained a good transient response to a preoperative ultrasound-guided subscapular cortisone injection obtained a significantly better recovery than those who did not. A preoperative ultrasound-guided subscapular cortisone injection appeared to be of prognostic value.  相似文献   

19.
OBJECTIVE: To assess the long-term efficacy of radiofrequency ablation (RFA) and percutaneous ethanol (EtOH) injection treatment of local recurrence or focal distant metastases of well-differentiated thyroid cancer (WTC). BACKGROUND: RFA and EtOH injection techniques are new minimally invasive surgical alternatives for treatment of recurrent WTC. We report our experience and long-term follow-up results using RFA or EtOH ablation in treating local recurrence and distant focal metastases from WTC. METHODS: Twenty patients underwent treatment of biopsy-proven recurrent WTC in the neck. Sixteen of these patients had lesions treated by ultrasound-guided RFA (mean size, 17.0 mm; range, 8-40 mm), while 6 had ultrasound-guided EtOH injection treatment (mean size, 11.4 mm; range, 6-15 mm). Four patients underwent RFA treatment of focal distant metastases from WTC. Three of these patients had CT-guided RFA of bone metastases (mean size, 40.0 mm; range, 30-60 mm), and 1 patient underwent RFA for a solitary lung metastasis (size, 27 mm). Patients were then followed with routine ultrasound, I whole body scan, and/or serum thyroglobulin levels for recurrence at the treatment site. RESULTS: No recurrent disease was detected at the treatment site in 14 of the 16 patients treated with RFA and in all 6 patients treated with EtOH injection at a mean follow-up of 40.7 and 18.7 months, respectively. Two of the 3 patients treated for bone metastases are free of disease at the treatment site at 44 and 53 months of follow-up, respectively. The patient who underwent RFA for a solitary lung metastasis is free of disease at the treatment site at 10 months of follow-up. No complications were experienced in the group treated by EtOH injection, while 1 minor skin burn and 1 permanent vocal cord paralysis occurred in the RFA treatment group. CONCLUSIONS: RFA and EtOH ablation show promise as alternatives to surgical treatment of recurrent WTC in patients with difficult reoperations. Further long-term follow-up studies are necessary to determine the precise role these therapies should play in the treatment of recurrent WTC.  相似文献   

20.
The aim of this study was to evaluate whether the association of exercises for the shoulder with ultrasound-guided injection into the bursa significantly improves the treatment outcome in adhesive bursitis. Two groups of 35 patients, one treated with ultrasound-guided injection (UGI) and the other one with ultrasound-guided injection and home exercise program (UGI-exercise) for 1 month, were assessed for pain and shoulder function before treatment, 1 and 3 months post-treatment. Fourteen patients in UGI group and 23 patients in the UGI-exercises group were completely free of pain after 1 month (p = 0.031). At 3 months' follow-up, patients in the UGI-exercise group showed a significant improvement with respect to the other group (p = 0.005). No differences were found in function assessment. The UGI combined with shoulder exercises in the treatment of subacromial adhesive bursitis is effective to ensure a more frequent complete pain relief in the medium term.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号